1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Hua, Q.X.
Hu, S.Q.
Frank, B.H.
Jia, W.H.
Chu, Y.C.
Wang, S.H.
Burke, G.T.
Katsoyannis, P.G.
Weiss, M.A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
264
390
403
10.1006/jmbi.1996.0648
8951384
Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue.
1996
10.2210/pdb1vkt/pdb
pdb_00001vkt
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
2351.568
INSULIN
CHAIN A, C6S, C11S, CHAIN B, H10D, P28K, K29P
1
man
polymer
3410.894
INSULIN
CHAIN A, C6S, C11S, CHAIN B, H10D, P28K, K29P
1
man
polymer
no
no
GIVEQSCTSISSLYQLENYCN
GIVEQSCTSISSLYQLENYCN
A
polypeptide(L)
no
no
FVNQHLCGSDLVEALYLVCGERGFFYTKPT
FVNQHLCGSDLVEALYLVCGERGFFYTKPT
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
PANCREAS
Homo sapiens
human
Homo
sample
9606
PANCREAS
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-04-01
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1996-10-14
REL
REL
DATE OF DATA COLLECTION : 1995
10
6.8
298
K
BRUNGER
refinement
X-PLOR
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
SER
6
n
6
SER
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
SER
11
n
11
SER
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
ASP
10
n
10
ASP
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
LYS
28
n
28
LYS
28
B
PRO
29
n
29
PRO
29
B
THR
30
n
30
THR
30
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
B
ARG
22
0.147
SIDE CHAIN
2
B
ARG
22
0.294
SIDE CHAIN
3
B
ARG
22
0.227
SIDE CHAIN
4
B
ARG
22
0.195
SIDE CHAIN
5
B
ARG
22
0.277
SIDE CHAIN
6
B
ARG
22
0.281
SIDE CHAIN
7
B
ARG
22
0.175
SIDE CHAIN
8
B
ARG
22
0.105
SIDE CHAIN
9
B
ARG
22
0.232
SIDE CHAIN
10
B
ARG
22
0.230
SIDE CHAIN
1
A
VAL
3
79.67
179.70
1
A
GLU
4
85.06
-11.21
1
A
GLN
5
-112.78
-77.19
1
A
CYS
7
62.50
-5.91
1
A
THR
8
35.79
-119.35
1
A
SER
11
-108.48
50.49
1
A
SER
12
-163.03
7.80
1
B
ASN
3
54.02
173.74
1
B
HIS
5
61.05
68.28
1
B
CYS
7
-2.07
-48.47
2
A
GLU
4
-150.75
21.62
2
A
GLN
5
-144.04
-112.77
2
A
SER
6
-84.84
46.98
2
A
CYS
7
47.26
19.13
2
A
THR
8
2.26
-126.63
2
A
SER
9
94.82
-0.52
2
A
ILE
10
-90.65
-76.50
2
A
SER
12
-160.59
-11.53
2
B
VAL
2
65.71
-170.33
2
B
ASN
3
-156.56
48.55
2
B
GLN
4
154.16
141.03
2
B
HIS
5
62.79
75.46
2
B
LEU
6
-130.01
-72.81
2
B
CYS
7
13.26
179.81
2
B
VAL
12
-97.44
-68.86
2
B
CYS
19
-93.01
-70.07
2
B
PHE
25
-160.98
99.27
3
A
ILE
2
56.03
146.07
3
A
GLN
5
-128.98
-75.07
3
A
THR
8
-74.93
-97.83
3
A
SER
11
-32.21
-32.65
3
B
VAL
2
-102.00
63.99
3
B
ASN
3
-19.70
138.42
3
B
GLN
4
80.58
113.87
3
B
HIS
5
77.18
56.26
3
B
LEU
6
-125.28
-74.93
3
B
CYS
7
15.24
-157.29
3
B
CYS
19
-104.55
-69.34
3
B
GLU
21
-96.39
49.18
3
B
PHE
24
-161.20
97.93
3
B
PHE
25
-100.82
79.72
4
A
ILE
2
-157.85
37.32
4
A
VAL
3
-163.21
115.45
4
A
GLU
4
-175.57
24.33
4
A
GLN
5
-162.44
-90.63
4
A
CYS
7
48.20
28.40
4
A
THR
8
-18.63
-114.87
4
A
SER
12
-160.72
92.80
4
B
ASN
3
-177.04
142.67
4
B
HIS
5
128.26
99.07
4
B
LEU
6
-145.21
-61.72
4
B
CYS
7
33.60
-159.46
4
B
CYS
19
-82.85
-71.65
4
B
GLU
21
-112.15
64.60
4
B
TYR
26
42.39
-174.29
4
B
LYS
28
-26.43
145.79
5
A
ILE
2
-66.89
-173.84
5
A
VAL
3
64.48
172.16
5
A
GLU
4
86.28
-7.45
5
A
GLN
5
-103.26
-95.53
5
A
CYS
7
54.01
4.96
5
A
THR
8
22.65
-150.99
5
A
SER
9
108.06
7.40
5
A
ILE
10
-129.81
-70.12
5
B
ASN
3
67.70
146.24
5
B
HIS
5
77.29
58.88
5
B
CYS
7
-57.51
-162.31
5
B
CYS
19
-66.40
-82.19
5
B
ARG
22
159.89
30.84
5
B
PHE
25
-143.52
51.59
5
B
TYR
26
-38.74
148.96
5
B
LYS
28
170.34
-53.55
6
A
ILE
2
-123.89
-167.71
6
A
VAL
3
-36.07
122.58
6
A
GLN
5
-167.90
-96.35
6
A
THR
8
23.91
75.31
6
A
SER
11
34.08
34.48
6
A
SER
12
-161.01
-31.18
6
B
VAL
2
-178.47
63.74
6
B
ASN
3
-164.63
70.44
6
B
GLN
4
-50.93
175.30
6
B
HIS
5
61.89
156.59
6
B
LEU
6
138.70
-52.97
6
B
CYS
7
22.99
-154.39
6
B
CYS
19
-95.80
-65.68
6
B
GLU
21
-114.33
68.39
6
B
PHE
25
-153.73
60.10
7
A
ILE
2
-61.95
94.03
7
A
VAL
3
162.03
-19.47
7
A
GLN
5
-77.08
-139.77
7
A
THR
8
8.14
110.25
7
A
SER
11
-103.26
45.84
7
A
SER
12
-139.32
-43.00
7
A
LEU
13
-34.48
-76.20
7
A
LEU
16
-69.99
1.58
7
B
ASN
3
48.98
124.18
7
B
HIS
5
82.07
59.82
7
B
CYS
7
11.16
-149.10
7
B
SER
9
-52.77
-9.15
7
B
GLU
21
-105.62
53.47
7
B
PHE
25
-160.40
85.40
8
A
VAL
3
83.64
-45.85
8
A
GLN
5
-114.98
-140.92
8
A
THR
8
-27.45
98.52
8
A
ILE
10
-90.92
-79.76
8
A
SER
11
-90.79
53.14
8
A
SER
12
-160.45
-32.64
8
A
GLU
17
-68.09
10.17
8
B
HIS
5
67.25
93.62
8
B
LEU
6
-144.52
-56.08
8
B
CYS
7
25.18
-156.64
8
B
CYS
19
-98.49
-71.74
8
B
ARG
22
169.79
30.51
8
B
PHE
25
-150.56
67.71
8
B
LYS
28
169.01
-54.57
8
B
PRO
29
-78.75
-168.45
9
A
ILE
2
49.66
-176.37
9
A
GLN
5
165.22
-90.81
9
A
CYS
7
49.98
27.91
9
A
THR
8
-25.32
89.03
9
A
ILE
10
-82.39
-75.07
9
A
SER
11
-88.56
46.90
9
A
SER
12
-160.95
-29.74
9
B
ASN
3
81.90
152.72
9
B
HIS
5
74.37
100.00
9
B
LEU
6
-145.95
-74.84
9
B
CYS
7
33.57
177.39
9
B
VAL
12
-94.59
-62.39
9
B
CYS
19
-105.12
-64.64
9
B
ARG
22
158.25
37.78
9
B
PHE
25
-160.66
94.27
10
A
VAL
3
51.56
-156.49
10
A
GLN
5
-129.95
-137.13
10
A
CYS
7
85.60
-31.07
10
A
THR
8
34.29
32.28
10
A
SER
11
53.51
19.54
10
A
SER
12
-160.67
52.44
10
B
ASN
3
78.25
145.90
10
B
HIS
5
60.12
95.23
10
B
LEU
6
-147.79
-58.74
10
B
CYS
7
26.13
-158.17
10
B
CYS
19
-110.69
-72.98
10
B
PHE
25
-151.40
42.39
10
B
LYS
28
33.32
71.22
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES
1
N
N
2
N
N
A
LEU
13
A
LEU
13
HELX_P
A
TYR
19
A
TYR
19
1
1
7
B
SER
9
B
SER
9
HELX_P
B
CYS
19
B
CYS
19
1
2
11
disulf
2.009
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.020
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
HORMONE
HORMONE, HUMAN INSULIN, DISULFIDE MODEL
INS_HUMAN
UNP
1
90
P01308
INS_HUMAN
UNP
2
25
P01308
90
110
1VKT
1
21
P01308
A
1
1
21
25
54
1VKT
1
30
P01308
B
2
1
30
1
CYS
engineered mutation
SER
6
1VKT
A
P01308
UNP
95
6
1
CYS
engineered mutation
SER
11
1VKT
A
P01308
UNP
100
11
2
HIS
engineered mutation
ASP
10
1VKT
B
P01308
UNP
34
10
2
PRO
engineered mutation
LYS
28
1VKT
B
P01308
UNP
52
28
2
LYS
engineered mutation
PRO
29
1VKT
B
P01308
UNP
53
29
1
P 1